Cellomatics BioSciences Ltd.

Cellomatics BioSciences Ltd. is a Nottingham-based preclinical-stage contract research organization (CRO) that provides support for drug development. In this article, we investigate and summarize the features of the company's contract non-clinical study services, the disease models it offers, and examples of non-clinical studies.

Cellomatics BioSciences Ltd.' Contract Nonclinical Trial Services Feature

Custom assay development to meet client needs

Cellomatics BioSciences Ltd,Develop assays (test methods) to help evaluate the efficacy of test compounds and provide customized servicesWe do this service. This service considers a variety of factors, including relevance, reproducibility, quality, interference, and cost,Customization to meet client needs and support from planning to completionI will do so.

We develop a variety of in vitro assays, primarily for biopharmaceutical and biotechnology companies. We provide the screening and evaluation needed at each stage of a drug development program.

A wide variety of facilities

To meet the diverse experimental needs of its clients, Cellomatics BioSciences Ltd. has installed a variety of equipment. The company has a powerful high-resolution imaging platform, theImageXpress® Pico Automated Cell Imaging Systemand high performance flow cytometer with user-friendly operation screen2020 Attune NxT Flow CytometerWe have also introduced a new system for the production of cellular biology. Through these investments, we are strengthening our technical capabilities to meet the needs of molecular cell biology.

Develop in vitro models with high predictive validity

Advanced in vitro experimental platform designed to reproduce human physiology, disease pathophysiology, and pharmacological responsesDevelopment of Translational Human Preclinical ModelsWe are currently working on a new series of models. These models encompass primary human cells, induced pluripotent stem cell-derived models, organoids, and 3D co-culture systems, and can provide higher predictive validity than traditional models.

Example of a pathological model owned by Cellomatics BioSciences Ltd.

INNOBEX, developed by Cellomatics BioSciences Ltd., is,Models designed to reproduce the complex structure and function of the human blood-brain barrier (BBB)It is. Using this model, drug compounds and their interactions within the BBB can be analyzed in detail. The company also uses primary human keratinocytes (keratinocytes) and freshly isolated immune cells,Also offers a model that faithfully reproduces the characteristics of psoriasisThe company is doing so.

Cellomatics BioSciences Ltd. Non-clinical Case Studies

No specific case studies were available on the official website.

Cellomatics BioSciences Ltd. Company Information

Cellomatics BioSciences Ltd. was founded in 2015. It provides preclinical in vitro bioassay services, specializing in therapeutic areas such as oncology, immuno-oncology, immunology and inflammation. The company evaluates the efficacy and safety of drugs to support research and development decisions.